Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

Continued medication important for heart failure patients Date: March 17, 2025 Source: Karolinska Institutet Summary: Patients who have been treated for heart failure and experience an improvement ...

Patients with heart failure who experience improved heart function remain at increased risk of heart-related death or hospitalization if they discontinue medications such as RASi, ARNi, or MRA.

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalisation if they stop taking heart ...